Key Highlights
- Atomic Alchemy, Oklo’s subsidiary, obtained its inaugural NRC materials license for isotope handling, processing, and distribution at its Idaho facility.
- This regulatory approval unlocks commercial isotope sales from the Idaho Radiochemistry Laboratory, creating a fresh revenue channel for the currently pre-revenue enterprise.
- This authorization differs from licensing for Oklo’s primary advanced nuclear reactors — those systems continue awaiting NRC clearance before power generation begins.
- Oklo finalized a fresh partnership with the U.S. Department of Energy to facilitate development of its inaugural reactor at Idaho National Laboratory.
- Shares climbed 4.6% during premarket hours before the company’s quarterly financial report scheduled for Tuesday evening.
Tuesday brought regulatory progress for Oklo, albeit with an important caveat. The nuclear energy company disclosed that the Nuclear Regulatory Commission granted its inaugural materials license — though the recipient was Atomic Alchemy, the wholly-owned subsidiary Oklo brought into its fold in 2025, rather than the parent company directly.
This authorization permits Atomic Alchemy to accept, warehouse, handle, and sell isotopes through its Idaho Radiochemistry Laboratory located in Idaho Falls. The specific license covers handling up to 2 Curies of Ra-226, alongside Co-60 and Am-241 designated for calibration applications.
These isotope materials face expanding market demand throughout medical applications, scientific research, industrial manufacturing, and national defense sectors. Oklo’s CEO Jacob DeWitte articulated the challenge succinctly: “Demand for critical isotopes is rising, but U.S. supply remains limited.”
The near-term business implications are tangible. Atomic Alchemy gains authorization to launch initial commercial transactions from its Idaho operations, representing the inaugural revenue-generating capability within Oklo’s corporate structure. The parent organization continues operating without revenue currently.
Crucially, this development shouldn’t be confused with the reactor authorization market observers have been anticipating. Oklo’s advanced fast reactor technology remains under NRC evaluation. Until that approval materializes, Oklo lacks authorization to distribute electricity — which constitutes its fundamental long-range business model.
Scope and Details of the Authorization
The NRC issued this license following comprehensive evaluation procedures and physical inspection of the Idaho location. Atomic Alchemy’s operations will focus on reclaiming and processing decommissioned radium sources — materials historically classified as waste products — converting them into production inputs for medical isotope manufacturing, particularly for targeted alpha therapy applications.
Beyond immediate operations, the laboratory work supports broader strategic objectives. Atomic Alchemy is engineering a multi-reactor isotope production complex featuring up to four Versatile Isotope Production Reactor (VIPR) units, each rated at approximately 15 MWth output capacity.
Tuesday’s announcements included a second development. Oklo revealed it executed an arrangement with the U.S. Department of Energy supporting design work, construction activities, and operational planning for its initial reactor installation at Idaho National Laboratory, operating within the DOE’s Reactor Pilot Program framework.
The Meta Agreement and Financial Reporting Ahead
Oklo’s nuclear energy initiatives have secured attention from a prominent technology partner. The firm maintains a collaborative agreement with Meta Platforms for developing a nuclear energy campus in southeastern Ohio. BofA Securities characterized this arrangement as “one of a few firm, binding partnerships today” across the broader nuclear power sector.
Shares advanced 4.6% in premarket activity Tuesday as market participants processed the regulatory developments. Oklo has quarterly financial results scheduled for release following Tuesday’s market close.
The enterprise targets commercial nuclear electricity generation commencing during late 2027 or throughout 2028.
